Methotrexate management for placenta accreta: a prospective study
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Objective To observe efficacy following methotrexate (MTX) management in women with placenta accreta. Methods Twenty-four stable patients with placenta accreta were treated with MTX. Beta-hCG values, vascular indices of the residual placenta, and other clinical characteristics were collected prospectively and were compared between the success and failure groups. Results After MTX management, the residual placentas were expulsed spontaneously in 33.3% of the patients. This was done through dilatation and curettage (D & C) in 45.8% of the patients. The residuals in the uterine wall were completely absorbed within 5.7 months. In the patients who were successfully treated with MTX, their beta-hCG values and vascular indices of the placentas decreased faster than those of failure patients (P Conclusions MTX management, when the beta-hCG value and vascular indices of placenta decreased significantly, is a conservative option for a stable patient with placenta accreta in China. 3D power Doppler ultrasound should be utilized for the follow-up of this condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One woman did suffer liver damage and the risks of this therapy must be balanced against the unproven benefit.”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [197]
In the citing paper
“There was no control group of women who did not receive MTX and so it is unknown whether or not the MTX was clinically helpful.”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [197]
In the citing paper
“An observational case series, including 24 women with placenta accreta left in situ after delivery and treated with MTX, reported placental delivery in 33.3% of the cases (spontaneously in 55%, and in 45% following dilatation and surgical evacuation).197”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [197]
Citations
Cites
Three‐dimensional power Doppler sonography: imaging and quantifying blood flow and vascularization
Pairleitner, H., Steiner, H., Hasenoehrl, G., & Staudach, A. (1999) · Ultrasound in Obstetrics & Gynecology · doi:10.1046/j.1469-0705.1999.14020139.x · Cited by 388
Placenta Accreta—Summary of 10 Years: A Survey of 310 Cases
Gielchinsky, Y., Rojansky, N., Fasouliotis, S. J., & Ezra, Y. (2002) · Placenta · doi:10.1053/plac.2001.0764 · Cited by 376 · cited 1×
“The diagnosis of placenta accreta was based on clinical or histological findings [6], including the presence of the following: (a) difficult manual, piecemeal removal of the placenta was performed if no evidence of placental separation was noticed at least 20 min after parturition, and despite active management of the…”
MethodConservative Management of Abnormally Invasive Placentation
Timmermans, S., van Hof, A. C., & Duvekot, J. J. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000271133.27011.05 · Cited by 270 · cited 2×
“7 % (2/3), respectively, in women suffered from placenta accreta without additional treatments [11], poorer than the present outcome with 33.”
ResultShih, J. C., Jaraquemada, J. M. P., Su, Y. N., Shyu, M. K., Lin, C. H., Lin, S. Y., & Lee, C. N. (2009) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.6284 · Cited by 249
FOX, H. (1972) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-197207000-00001 · Cited by 218 · cited 1×
“Conventional management of this condition has long been extirpative given that mortality rates approached 25 % with conservative measures, but these rates were lowered to only 6 % with prompt hysterectomy [1].”
BackgroundSecondary postpartum haemorrhage: incidence, morbidity and current management
Hoveyda, F., & MacKenzie, I. Z. (2001) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2001.00230.x · Cited by 180 · cited 1×
“This is often a result of attempted manual placental separation from its poorly formed decidual bed, which opens up large-caliber spiral vessels and sinuses [9].”
BackgroundMedical Treatment of Placenta Accreta with Methotrexate
Arulkumaran, S., Ng, C. S. A., Ingemarsson, I., & Ratnam, S. S. (1986) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016348609155187 · Cited by 153 · cited 1×
“Therefore, MTX is assumed to affect the placental tissue by reducing its vascularity, leading to placental necrosis and thus rapid placental involution [5, 12, 13].”
BackgroundCommittee opinion #270: bone density screening for osteoporosis
Committee on Gynecologic Practice (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)01943-9 · Cited by 132
Diagnosis and management of placenta accreta
Palacios-Jaraquemada, J. M. (2008) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2008.08.003 · Cited by 123
de Paula, C. F. S., Ruano, R., Campos, J. A. D. B., & Zugaib, M. (2009) · Placenta · doi:10.1016/j.placenta.2008.11.010 · Cited by 111 · cited 1×
“This way, the quantitative blood flow [14, 15] and placental involution situation [16, 17] were derived.”
BackgroundNonsurgical management of placenta percreta: a case report.
Legro, R. S., Price, F. V., Hill, L. M., & Caritis, S. N. (1994) · PubMed · Cited by 98
CELLULAR GROWTH IN HUMAN PLACENTA
Winick, M., Coscia, A., & Noble, A. (1967) · PEDIATRICS · doi:10.1542/peds.39.2.248 · Cited by 98
Cellular growth in human placenta. I. Normal placental growth.
Winick, M., Coscia, A., & Noble, A. (1967) · PubMed · Cited by 88
Cellular growth in human placenta
Winick, M., & Noble, A. (1967) · The Journal of Pediatrics · doi:10.1016/s0022-3476(67)80075-1 · Cited by 88
Committee opinion #266: placenta accreta
ACOG Committee on Obstetric Practice (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01748-3 · Cited by 82
Secondary postpartum haemorrhage: incidence, morbidity and current management
Hoveyda, F., & MacKenzie, I. Z. (2001) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1016/s0306-5456(01)00230-3 · Cited by 48
Matsumura, N., Inoue, T. K., Fukuoka, M., Sagawa, N., & Fujii, S. (2000) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2000.tb01288.x · Cited by 47 · cited 2×
“[17], blood loss during subsequent placental removal was less when serum betahCG levels were lower than 100 IU/L.”
BackgroundConservative treatment of placenta increta with methotrexate
Raquel Crespo, E., Moros, M. L., & Madani, B. (2005) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2005.06.028 · Cited by 30 · cited 2×
“Methotrexate (MTX) management is a common and simple approach, with some case reports showing that it could lead to rapid placental involution [2, 3].”
BackgroundResultMethotrexate treatment for retained placental tissue
FLAM, F., Karlstrom, P. O., Carlsson, B., & Garoff, L. (1999) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(98)00270-x · Cited by 22 · cited 2×
“The result suggested that the expulsion of residual placentas was associated with not only rapid placental involution but also reduced blood supply, which is in accordance with the fact that MTX management cured the retained placenta with vascularity despite undetectable hCG levels [13].”
BackgroundResultPartial placenta increta and methotrexate therapy: three case reports.
Pinho, S. M. E. D. P., Sarzedas, S., Pedroso, S. K. B., dos Santos, A. H., Rebordão, M. A., Avillez, T., Casal, E., & Hermida, M. (2008) · PubMed · Cited by 22
Lathrop, E., & Schreiber, C. (2011) · Contraception · doi:10.1016/j.contraception.2011.08.011 · Cited by 13
Kulkarni, A., & Draycott, T. J. (2005) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050500072565 · Cited by 9
Cited by
Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a
Jauniaux, E., Alfirevic, Z., Bhide, A., Belfort, M., Burton, G., Collins, S., Dornan, S., Jurkovic, D., Kayem, G., Kingdom, J., et al. (2019) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15306 · Cited by 506
“3% of the cases (spontaneously in 55%, and in 45% following dilatation and surgical evacuation).(197) There was no control group of women who did not receive MTX and so it is unknown whether or not the MTX was clinically helpful.”
BackgroundFIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management,
Sentilhes, L., Kayem, G., Chandraharan, E., Palacios‐Jaraquemada, J., Jauniaux, E., & Panel, F. T. F. P. A. D. A. M. E. C. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12410 · Cited by 322
Cui, R., Li, M., Lu, J., Bai, H., & Zhang, Z. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1935-6 · Cited by 39
Karaman, E., Kolusarı, A., Çetin, O., Çim, N., Alkış, İ., Yıldızhan, R., Şahin, H. G., & Gül, A. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1192119 · Cited by 35
Fitzgerald, G. D., Newton, J. M., Atasi, L. K., Duzyj, C. M., Luna, J. M. B., Burnett, B., Carver, A. R., Cheng, C., Conyers, S., Davitt, C. C., et al. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.101229 · Cited by 35
Metadata
- Authors
- Lin, K., Qin, J., Xu, K., Hu, W., & Lin, J.
- Affiliations
- Women's Hospital, School of Medicine, Zhejiang University (CN)
- Corresponding author
- Lin, Jun
- Venue
- Archives of Gynecology and Obstetrics
- Published
- 2014-12-11
- Volume
- 291
- Issue
- 6
- Pages
- 1259-1264
- ISSN
- 0003-9128 (ISSN-L)
- 0932-0067
- 1432-0711
- OpenAlex
- W2037046030
- Cited by
- 39
- References
- 22
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 9 · 2017: 3 · 2016: 6
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Gynecology and Obstetrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and fetal healthcare
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Trophoblastic Disease Studies
- Keywords
- placenta accreta, methotrexate, conservative treatment, spontaneous expulsion, dilatation and curettage, beta-hCG, placental vascularization, power Doppler, postpartum hemorrhage prevention
- MeSH terms
- Adult, China, Dilatation and Curettage, Female, Follow-Up Studies, Humans, Methotrexate, Placenta, Placenta Accreta, Pregnancy, Prospective Studies, Ultrasonography, Uterus, Chorionic Gonadotropin, beta Subunit, Human, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.